University of California San Francisco
Give to UCSF
A new brain cancer vaccine tailored to individual patients by using material from their own tumors has proven effective in a multicenter phase 2 clinical trial at extending their lives by several months or longer. The patients suffered from recurrent glioblastoma multiform — which kills thousands of Americans every year.
A new technique for analyzing brain images offers the possibility of using magnetic resonance imaging (MRI) to predict the rate of progression and physical path of many degenerative brain diseases, report scientists at the San Francisco VA Medical Center and the University of California, San Francisco.
<p>Nobel laureate Stanley Prusiner will talk about his prize-winning research about prions during the UCSF Osher Mini Medical School for the Public on April 16.</p>
Scientists at the UCSF-affiliated Gladstone Institutes have enhanced the understanding of how a protein linked to Alzheimer’s disease keeps young brains healthy, but can damage them later in life — suggesting new research avenues for treating this devastating disease.
A new study raises hopes that physicians may be able to use MRI to predict the course of dementias and that researchers may use these predicted outcomes to determine whether a new treatment is working.
A group of scientists at UCSF has discovered that a tiny molecule in the fly’s brain govern the behavior of males who go on a drinking binge after female fruit flies reject their sexual advances.
Neurologist Bruce Miller, MD, director of the UCSF Memory and Aging Center, participated in a roundtable discussion on Alzheimer’s disease and frontotemporal dementia on the "Charlie Rose Show."
Dogs with spinal cord injuries may soon benefit from an experimental drug being tested by researchers at UCSF and Texas A&M College of Veterinary Medicine & Biomedical Sciences — work that they hope will one day help people with similar injuries.
An experimental drug called Ocrelizumab has shown promise in a Phase 2 clinical trial involving 220 people with multiple sclerosis (MS), an often debilitating, chronic autoimmune disease that affects an increasing number of people in North America.